Understand the source comparison
Best Peptides for Gut Inflammation: Clinical Comparison
The table below compares the three most studied anti-inflammatory peptides for gut conditions. Each peptide targets a different mechanism. Selecting the right one requires matching the inflammatory pathway to the peptide's receptor action. KPV 5MG NF-κB inhibi
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below compares the three most studied anti-inflammatory peptides for gut conditions. Each peptide targets a different mechanism. Selecting the right one requires matching the inflammatory pathway to the peptide's receptor action.
- KPV 5MG
- NF-κB inhibition in intestinal epithelial cells
- IBD, colitis, NF-κB-driven inflammation
- 200–400 mcg twice daily
- 85–90%
- Most direct anti-inflammatory action for acute flares. Requires consistent dosing to maintain NF-κB suppression
- BPC-157
- VEGF upregulation, angiogenesis, mucosal repair
- Gastric ulcers, intestinal fistulas, structural damage
- 200–500 mcg twice daily
- 80–85%
- Best for tissue repair and vascular insufficiency. Limited effect on autoimmune inflammation without structural damage
- Thymosin Alpha-1
- T-cell modulation, Th1/Th2 rebalancing
- Chronic IBD with systemic immune dysregulation
- 0.8–1.2 mg 2–3× weekly
- 75–80%
- Addresses upstream immune imbalance. Requires 8–12 weeks minimum to demonstrate effect, not suitable for acute symptom relief